Background and aim: Primary sclerosing cholangitis (PSC) is one of the most famous liver cholestatic
diseases, which leads to liver cirrhosis and liver failure. Hepatitis B virus (HBV)
also leads to liver cirrhosis and hepatocellular carcinoma (HCC). Abcb4 knock out
(Abcb4-/-) mice are known to develop cholangiopathy represented by portal tract inflammation
and a severe ductal proliferation and developed nodules and HCC. Also, HBV transgenic
mice (HBV+/-), which show liver specific expression of the large envelope polypeptide
of human HBV, lead to liver damage and HCC. We already reported that these mice lead
to liver inflammation and fibrosis. The aim of the present study is to clarify the
signaling pathways involved in carcinogenesis in one-year old Abcb4-/-/HBV+/- hybrid
mice.
Methods: Abcb4-/-/HBV+/-mice were raised by crossing Abcb4-/- with HBV+/- on BALB/c background.
We performed serum analysis, hydroxyproline measurement, qRT-PCR, and Western blots.
Results: The rate and size of HCC in HBV+/- and Abcb4-/-/HBV+/- are higher than those of super
controls (WT) andAbcb4-/- mice. Serum ALT levels in Abcb4-/-, HBV+/- and Abcb4-/-/HBV+/-
mice are significantly higher than in WT. Hydroxyproline, Collagen1 and TIMP-1-transcription
in Abcb4-/- and Abcb4-/-/HBV+/- mice are higher than in WT and HBV+/-. Phospho(P)-JNK,
P-cJun and P-STAT3 in Abcb4-/-/HBV+/- are increased in comparison to controls.
Conclusion: Double injuryin combined Abcb4-/- and HBV+/-mice resulted in raised inflammation,
fibrosis and signaling pathways which seem to be involved in enhanced carcinogenesis.
The new mouse model might be a valuable tool to study immunologic mechanisms of human
HBV associated cholangitis and associated complications.